On May 18th, the clinical application of CEREBRAL aneurysms its related vascular MRA imaging and key technologies of interventional treatment, which based on clinical research of WILLIS® intracranial graft stent obtained the First Class Award of Science and Technology Progress issued by the Ministry of Education. MicroPort, as one of the co-sponsors for the research project, won the award together with Shanghai Sixth People's Hospital.
WILLIS® intracranial stent is the first graft stent product that is indicated for the treatment of intracranial aneurysms. WILLIS® intracranial graft stent can isolate and make occlusion of the aneurysm, as well as reserve the aneurysm artery patency and restore normal blood flow in the lesions area. WILLIS® clinical trials have successfully achieved its research hypothesis: six months' total occlusive ratio of aneurysm was superior to the method of coil embolization.